A National Institutes of Health researcher's lab jacket, embroidered with the NIH logo with blue chevron detail. (Photo courtesy NIH)
WASHINGTON — President Donald Trump signed an executive order Monday establishing a Women’s Health Division within the National Institutes of Health.
The new division is set to work with the agency’s existing Office of Research on Women’s Health, which was established in 1990 and “has served as the focal point for women’s health research at NIH,” according to the NIH website.
The White House said first lady Melania Trump was involved in formulating and leading work on the order, which also creates a White House Women’s Health Task Force that Health and Human Services Secretary Robert F. Kennedy Jr. and White House Chief of Staff Susie Wiles will co-chair.
The order is meant to “strengthen research, prevention, diagnosis, treatment, and care for women and girls throughout every stage of life,” according to a White House fact sheet.
The order says it “is the policy of the United States to prioritize translating research into improved clinical care that benefits women and girls through a comprehensive approach to women’s health that recognizes evolving health needs from infancy, childhood, and adolescence through pregnancy, midlife, menopause, and aging, and supports timely, stage-specific prevention, diagnosis, treatment, and care.”
The order does not mention research into contraception or reproductive rights. The Food and Drug Administration is conducting an ongoing safety review into abortion medication.
Reshaping NIH
The initiative came just two weeks ahead of the midterms, as the GOP vies to maintain its razor-thin majority in the U.S. House and Senate. The order also followed many other announcements on new projects by the administration in the days leading up to Election Day on Nov. 3.
The Trump administration has sought to reshape NIH to align with its political priorities and has sought to cut its funding, prompting pushback from Congress. NIH, the country’s largest research agency, is housed under the U.S. Department of Health and Human Services.
“Today, we’re taking historic action to promote women’s health through all phases of life,” Trump said during a signing ceremony at the White House Rose Garden alongside the first lady.
“Despite amazing advances in medical science, many diseases and conditions that disproportionately affect women remain chronically understudied,” the president added.
The first lady touted the effort as establishing a “new ambition, transforming hardship and pain into scientific discovery, effective treatments and lasting cures.”
Kennedy and Wiles were in attendance Monday, along with Agriculture Secretary Brooke Rollins, NIH Director Dr. Jay Bhattacharya, Centers for Disease Control and Prevention Director Dr. Erica Schwartz and Centers for Medicare and Medicaid Services Administrator Dr. Mehmet Oz, among others.
Trump said the order will promote “new research and really go after the understudied diseases affecting women and promote innovative technologies to diagnose conditions sooner and improve treatment using the best available science, and we’ve got that.”
The task force — which will hold its first meeting Monday — will “mobilize the entire federal government to coordinate action focused on improving women’s health,” Trump said.
Revoking Biden actions
Trump in his order also revoked a 2024 executive order by then-President Joe Biden that sought to improve women’s health research as well as a 2023 memorandum that had established the White House Initiative on Women’s Health Research.
The National Women’s Law Center criticized the administration for rolling out the order amid “major attacks on women’s health,” pointing to the GOP’s mega tax and spending cut law signed by Trump in 2025, which includes sweeping Medicaid cuts that axe roughly $1 trillion in program spending over 10 years.
“Women’s health has long been ignored as a federal priority, and while we agree that steps must be taken to close disparities in women’s health care, it’s hard not to point out the blatant hypocrisy of this unfunded order coming from an administration that is actively decimating health care access for women,” Dorianne Mason, senior director of health equity and contraceptive access at NWLC, said in a statement Monday.
Women practice yoga during a community yoga class in Tulsa, Okla., in 2021. New research produced by the University of Michigan finds an association between higher out-of-pocket health insurance expenses and states with abortion bans, with data showing differences were even higher for Black and Hispanic women. (Photo by Michael B. Thomas/Getty Images)
New preliminary research from the University of Michigan shows women living in states with post-Dobbs abortion bans may be more likely to shoulder costs for employer-sponsored health insurance premiums, with federal data reflecting a 5.4% increase in annual premium expenditures for those women after 2022, when most abortion bans went into effect.
The study used national data from the U.S. Census Bureau’s 2019-2025 Current Population Survey Annual Social and Economic Supplement to compare individual medical out-of-pocket costs for women of reproductive age between 18 and 44. The study, which hasn’t yet been published in a peer-reviewed journal, received financial support from the Center for Reproductive Rights, an advocacy group based in Washington, D.C.
“State abortion bans were associated with an increase in women’s likelihood of paying out-of-pocket for health insurance premiums,” the study said.
The findings also showed even higher premium expenditures for Black and Hispanic women, at 12.8% and 13.7%, respectively. The findings were not present among men, and the majority of the women in the sample had incomes above 250% of the federal poverty level.
“Our results are suggestive that post-Dobbs abortion bans led to insurers passing more premium costs to beneficiaries,” the study said. “Our findings shed light on the more far-reaching effects of abortion bans, quantifying the extent to which they pose an economic burden to individuals and families.”
Costs associated with pregnancy, childbirth and postpartum care averaged $20,416 nationally, including $2,743 in out-of-pocket expenses for women enrolled in employer plans over 2021-2023, according to previous research.
Joelle Abramowitz, an associate research scientist at the University of Michigan and co-author of the study, said the population survey — which is used to calculate poverty and health insurance coverage rates — was one of few sources that could offer recent insights.
“What we see is, prior to the bans, the outcomes were looking comparable, and then after the bans were implemented, we see them diverge, with more women paying health insurance premiums in the ban states,” said Abramowitz, an economist and co-director of Michigan Federal Statistical Research Data Centers. .
Ten states with near-total abortion bans — Alabama, Arkansas, Indiana, Kentucky, Louisiana, Mississippi, North Dakota, Tennessee, Texas and West Virginia — were included in the study and compared with five states that did not implement bans: Massachusetts, Michigan, New York, Pennsylvania and Washington. States that expanded Medicaid during that time frame — Idaho, Missouri, Oklahoma and South Dakota — were excluded from the analysis to isolate the effects of the bans from Medicaid changes.
Abramowitz said there could be several factors increasing premium costs for female patients. One is that in states with bans, pregnancies that might have been terminated before the bans became deliveries with the potential for more complications and higher risks.
Prior research has shown that abortion bans are also associated with a higher rate of negative maternal and infant health outcomes, including admissions to a neonatal intensive care unit, as well as higher rates of cesarean procedures, all of which can increase costs for insurers that get passed along through higher premiums.
“I think this is an example of one way that these policies have more far-reaching effects beyond just the individuals who are directly affected by them,” Abramowitz said.
This story was originally produced by Stateline, which is part of States Newsroom, a nonprofit news network which includes Wisconsin Examiner, and is supported by grants and a coalition of donors as a 501c(3) public charity.
Volunteer clinic escorts stand in a line before a kneeling anti-abortion demonstrator at a clinic in Louisville, Ky., in 2021. Advocates from each side of the abortion issue have pushed for Congress to either codify the Hyde Amendment into law or codify its repeal, but neither side has been successful. (Photo by Jon Cherry/Getty Images)
In the early months of 2022, Democrats in Congress came close to passing an appropriations bill that did not include a provision barring federal funding for abortions — maybe the closest it had ever come in more than 40 years.
But those who wanted the Hyde Amendment included won the battle in the end. Three months later, the U.S. Supreme Court made its decision in Dobbs v. Jackson Women’s Healthto allow states to regulate abortion access. That year, the 50-year precedent of a constitutional right to abortion ended, and the 50-year precedent of no federal tax funding to pay for abortions endures.
The Hyde Amendment was first passed Sept. 30, 1976, three years after the Roe decision. The clause — which isn’t a constitutional amendment — is named for Republican U.S. Rep. Henry Hyde of Illinois. It marked one of the first legislative victories for anti-abortion groups after Roe v. Wade guaranteed abortion access up to fetal viability.
In the decades since, it has been added to every appropriations bill passed by Congress, restricting federal Medicaid dollars from paying for abortion care except in limited cases of rape, incest and to prevent a pregnant patient’s death. The result has left countless people without a way to pay for the procedure, which advocates for abortion access say causes more abortions to happen later in pregnancy and unnecessarily endangers patients’ health.
Abortion opponents say the Hyde Amendment has prevented 2.7 million abortions. An estimated 300,000 abortions per year were covered by federal dollars prior to the Hyde Amendment. While there aren’t any major organizations that have published how much the federal government has saved by not funding abortion care, advocates say it costs the government more not to fund it because of the extra costs added to medical care and public assistance programs.
As more polls and strategists indicate Democrats could take over congressional majorities in the U.S. House of Representatives and the U.S. Senate in January, some anti-abortion advocates fear such a change could be the most serious threat to Hyde’s future since the party nearly repealed the amendment in 2022.
“If there becomes a pro-abortion majority in Congress, then Hyde is going to be one of the first things to go, probably, especially because it’s been in the spotlight more recently,” said Gavin Oxley, spokesperson for Americans United for Life, a national anti-abortion organization.
Advocates from each side of the issue have pushed for Congress to either codify Hyde into law or codify its repeal, but neither side has been successful. Because of filibuster rules that are usually used in the U.S. Senate on controversial pieces of legislation, legislation would likely need 60 votes to pass, a tall order in a highly polarized environment.
Quotation
There are some Republicans who may not be as committed to protecting Hyde.
– Gavin Oxley, spokesperson for Americans United for Life
Oxley said anti-abortion advocates aren’t worried just about Democrats, though. During negotiations over legislation that would have extended subsidies for premiums under the Affordable Care Act, President Donald Trumptold congressional Republicans in January that they needed to be “a little flexible” on including the Hyde Amendment. The bill never came to fruition and the subsidies expired, but the incident worried anti-abortion groups such as Oxley’s.
“If we get a pro-abortion majority (in Congress), then I would be concerned,” Oxley said. “There are some Republicans who may not be as committed to protecting Hyde.”
Anti-abortion groups tout polls showing strong support for keeping federal dollars from funding abortion care, but few nonpartisan polls have been conducted on the issue, and no major nonpartisan polls have surfaced in the years since 2022, when 13 states implemented near-total abortion bans. A2016 Politico poll conducted by the Harvard T.H. Chan School of Public Health found 58% of likely voters opposed using Medicaid to fund abortions.
When other polls commissioned by pro-abortion rights organizations have framed the question with language specific to how Hyde works, which is that a pregnant patient covered by Medicaid can have pregnancy care and childbirth covered but not the cost of an abortion,support for repealing the Hyde amendment goes up. A 2015 poll found that 62% of voters said Medicaid should cover abortion services.
Effects extend beyond abortion procedures
Amanda Jean Stevenson, associate professor of sociology and director of population at the University of Colorado, Boulder, said many scholars have tracked the fallout of the Hyde Amendment since its inception, but it’s difficult to trace pregnancy complications or deaths back to Hyde.
Many abortion rights advocates point to thecase of Rosie Jimenez, a 27-year-old Texas woman who was denied care at a clinic in 1977 because of her Medicaid status and instead sought care from an unlicensed midwife. She died from an infection after spending a week in intensive care. Her daughter, Monique, was 4 years old at the time and now advocates for policy change.
“It’s very easy for some people to say (Rosie Jimenez’s death) was caused by the Hyde Amendment,” Stevenson said. Had Medicaid benefits covered the abortion, “she probably would’ve had that option for safer care.”
Named after Republican U.S. Rep. Henry Hyde of Illinois, the Hyde Amendment was first passed Sept. 30, 1976. (Photo by Chip Somodevilla/Getty Images)
Jimenez’s case happened a few months after Hyde was first included in an appropriations bill, but it didn’t change its inclusion in future bills. Many scholars have documented the effects of low-income patients being denied coverage for abortions, but it hasn’t resulted in policy change, Stevenson said.
“People set out to find out about the impact of it, they find that it has a big adverse impact, and that doesn’t matter. It doesn’t change the policy or people’s opinion of it, it doesn’t change anything, really,” she said. “Evidence continues to be generated, and it continues to be ignored.”
Marlene Gerber Fried, co-founder and the former president of the National Network of Abortion Funds, said it would be nice to think that a change in Congress would bring about the end of Hyde, but she’s heard optimism of that kind before. When former Democratic President Bill Clinton took office in 1993, abortion-rights advocates also expected change.
In the years since, Fried said, the Hyde Amendment has been a “fault line” in the abortion rights space, even as some abortion rights advocates think they are gaining ground with public opinion.
“It’s not that they were against public funding, they just thought it wasn’t going to get to a win,” Fried said.
Researchers say Hyde doesn’t just affect the direct costs of abortion procedures. River Robbins, a doctoral candidate in applied medical anthropology and adjunct instructor at the University of South Florida, said his dissertation research has shown not having access to federal funding affects other services available at individual clinics. Independent clinics provide 58% of all abortions nationwide, according to data from the Abortion Care Network.
Many clinics serve low-income communities and people of color, including patients who need interpreters or other language or disability services. While hospital networks have access to funding that helps them provide those services, such money is not available to clinics that primarily exist to provide abortion care.
Hyde won’t be the end of funding challenges, advocates say
Now that access to abortion is extremely limited in more than a dozen states, even fewer people can rely on Medicaid to cover abortion costs. Those who can’t access abortion care at home often must travel to another state, where their local Medicaid program dollars won’t apply. That has put extra burdens on local and regional abortion funds and other philanthropic organizations to fill the funding gaps. Sometimes health clinics just take a loss rather than denying someone an abortion.
“We know that our providers don’t turn folks away, and sometimes that comes at great cost to their clinics and their ability to operate,” said Kelsey Ryland, policy counsel for the National Abortion Federation.
Chelsea Souder, co-owner of Hope Clinic in Illinois, said she hopes the Hyde Amendment will be permanently repealed in the near future, but that even if it is, there will still be many gaps in funding for abortion care.
Even in states with access, including some of the most accessible states in the country like Illinois, state Medicaid coverage is often inadequate to cover costs by itself, especially for those who need carelater in pregnancy. Souder said 85% of her clinic’s revenue does not come from patients who pay out of pocket or with Medicaid — it comes from abortion funds or donors, which she said is not sustainable.
“Making abortion actually accessible and affordable is where the focus has to be,” Souder said.
According to health policy institute KFF, 21 states allow their state Medicaid program to cover abortion costs, and some have expanded those policies since Roe fell. But reimbursement rates for providers continue to be low, regardless of where the clinic is located, and they are exceedingly low for abortions later in a pregnancy.
Dr. Diane Horvath, chief medical officer at Partners in Abortion Care in Maryland, said the clinic ran an experiment of accepting all state Medicaid patients for a year and a half, starting in 2024. Despite strong state support for abortion access at any stage in pregnancy, the low reimbursement rates for care beyond the second trimester resulted in a loss to the clinic of $1.2 million during that time. That includes cost increases for supplies and labor, since the clinic hasn’t increased prices for patients.
“For most of these patients, we lose at least $4,000 a patient,” Horvath said. “A hospital might be able to recover more and spread loss over different departments, but I don’t have another clinic, I don’t have another place I can draw funds from.”
This story was originally produced by Stateline, which is part of States Newsroom, a nonprofit news network which includes Wisconsin Examiner, and is supported by grants and a coalition of donors as a 501c(3) public charity.
Women gather to listen to President Donald Trump at a Women’s History Month event in the East Room of the White House in March 2025. The U.S. Food and Drug Administration this month acknowledged a nationwide shortage of estrogen-based hormonal patches, which are prescribed for women experiencing symptoms related to menopause. (Photo by Win McNamee/Getty Images)
The U.S. Food and Drug Administration says it’s helping manufacturers increase the supply of estrogen-based hormonal patches and acknowledged a current nationwide shortage as more women seek hormonal therapies for symptoms related to menopause.
In a release earlier this month, the FDA said it is expediting actions to increase supply, and said all six manufacturers are working to expand capacity and prioritize production of the patches.
“The FDA views increased interest in menopause treatment as an important development for women’s health and is working closely with manufacturers to help ensure that the supply of estradiol patches keeps pace with demand,” the release said.
Menopause typically occurs between the ages of 45 and 55, according to the National Institute on Aging, when a woman stops having menstrual periods. That hormonal change can cause symptoms such as hot flashes, night sweats, bone density loss, insomnia and more. Estradiol transdermal patches worn on the skin can replace estrogen lost through menopause and reduce those symptoms for some women.
Statelinereported in May that more awareness of menopause and its effects was leading to more states introducing legislation around the topic to mandate more insurance coverage for treatment and to create more workplace accommodations. At that time, the FDA did not list the patches in its list of shortages — this month marks the first time the agency has acknowledged a shortage. The American Society of Health-System Pharmacists first noted a shortagein January, two months after the FDA removed the treatment from its longtime “black box” warning status.
As of May, the National Menopause Foundation said more than 60 pieces of legislation related to menopause had been introduced nationwide this year. Twenty-six, and 26 states have enacted menopause-related laws since 2019, and more bills are expected to be introduced in the upcoming 2027 legislative sessions.
This story was originally produced by Stateline, which is part of States Newsroom, a nonprofit news network which includes Wisconsin Examiner, and is supported by grants and a coalition of donors as a 501c(3) public charity.